Operating Expenses: The sum of all operating expenses for the given industry.
Tonix Pharmaceuticals Holding Corp. (TNXP) had Operating Expenses of $56.08M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$13.54M |
|
$-40.55M |
|
$0.70M |
|
$12.84M |
|
|
Operating Expenses |
$56.08M |
$-42.53M |
|
$1.98M |
|
$-40.55M |
|
$-40.55M |
|
$-40.55M |
|
$-40.55M |
|
$-40.55M |
|
$-40.55M |
|
$-42.53M |
|
$-41.92M |
|
16.64M |
|
16.64M |
|
$-2.44 |
|
$-2.44 |
|
| Balance Sheet Financials | |
$203.43M |
|
$44.76M |
|
$50.66M |
|
$254.09M |
|
$30.79M |
|
-- |
|
$1.02M |
|
$31.81M |
|
$222.28M |
|
$222.28M |
|
$222.28M |
|
16.79M |
|
| Cash Flow Statement Financials | |
$-84.56M |
|
$-2.28M |
|
$53.71M |
|
$209.81M |
|
$176.62M |
|
$-33.19M |
|
$4.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.81% |
|
-314.05% |
|
-314.05% |
|
-- |
|
-299.41% |
|
-299.41% |
|
$-86.84M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
0.15 |
|
1.15 |
|
78.44 |
|
-18.24% |
|
-18.24% |
|
-15.96% |
|
-18.24% |
|
$13.24 |
|
$-5.22 |
|
$-5.08 |
|